Logo image of VRTS

VIRTUS INVESTMENT PARTNERS (VRTS) Stock Fundamental Analysis

NYSE:VRTS - US92828Q1094 - Common Stock

200.26 USD
+11.21 (+5.93%)
Last: 8/22/2025, 8:04:00 PM
200.26 USD
0 (0%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to VRTS. VRTS was compared to 237 industry peers in the Capital Markets industry. VRTS has an average financial health and profitability rating. VRTS is not valued too expensively and it also shows a decent growth rate. VRTS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year VRTS was profitable.
In the past year VRTS had a positive cash flow from operations.
In the past 5 years VRTS has always been profitable.
Of the past 5 years VRTS 4 years had a positive operating cash flow.
VRTS Yearly Net Income VS EBIT VS OCF VS FCFVRTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

VRTS has a Return On Assets (3.27%) which is comparable to the rest of the industry.
The Return On Equity of VRTS (13.49%) is better than 75.95% of its industry peers.
VRTS has a Return On Invested Capital (3.88%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VRTS is below the industry average of 7.69%.
The 3 year average ROIC (3.76%) for VRTS is below the current ROIC(3.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.27%
ROE 13.49%
ROIC 3.88%
ROA(3y)3.19%
ROA(5y)3.43%
ROE(3y)14.36%
ROE(5y)15.89%
ROIC(3y)3.76%
ROIC(5y)4.34%
VRTS Yearly ROA, ROE, ROICVRTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

VRTS has a Profit Margin (13.35%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of VRTS has declined.
VRTS has a Operating Margin of 20.14%. This is comparable to the rest of the industry: VRTS outperforms 42.19% of its industry peers.
VRTS's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.14%
PM (TTM) 13.35%
GM N/A
OM growth 3Y-17.09%
OM growth 5Y-2.7%
PM growth 3Y-14.2%
PM growth 5Y-2.84%
GM growth 3YN/A
GM growth 5YN/A
VRTS Yearly Profit, Operating, Gross MarginsVRTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, VRTS has less shares outstanding
Compared to 5 years ago, VRTS has more shares outstanding
VRTS has a worse debt/assets ratio than last year.
VRTS Yearly Shares OutstandingVRTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
VRTS Yearly Total Debt VS Total AssetsVRTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.86, we must say that VRTS is in the distress zone and has some risk of bankruptcy.
VRTS has a Altman-Z score (0.86) which is in line with its industry peers.
VRTS has a debt to FCF ratio of 87.76. This is a negative value and a sign of low solvency as VRTS would need 87.76 years to pay back of all of its debts.
VRTS has a Debt to FCF ratio (87.76) which is in line with its industry peers.
A Debt/Equity ratio of 2.54 is on the high side and indicates that VRTS has dependencies on debt financing.
With a Debt to Equity ratio value of 2.54, VRTS is not doing good in the industry: 81.01% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF 87.76
Altman-Z 0.86
ROIC/WACCN/A
WACCN/A
VRTS Yearly LT Debt VS Equity VS FCFVRTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

VRTS has a Current Ratio of 2.05. This indicates that VRTS is financially healthy and has no problem in meeting its short term obligations.
VRTS has a Current ratio of 2.05. This is in the better half of the industry: VRTS outperforms 70.04% of its industry peers.
VRTS has a Quick Ratio of 2.05. This indicates that VRTS is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.05, VRTS is doing good in the industry, outperforming 70.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 2.05
VRTS Yearly Current Assets VS Current LiabilitesVRTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

VRTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.82%, which is quite good.
Measured over the past years, VRTS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.37% on average per year.
The Revenue has been growing slightly by 0.99% in the past year.
VRTS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.00% yearly.
EPS 1Y (TTM)8.82%
EPS 3Y-9.8%
EPS 5Y12.37%
EPS Q2Q%-4.29%
Revenue 1Y (TTM)0.99%
Revenue growth 3Y-2.52%
Revenue growth 5Y10%
Sales Q2Q%-5.91%

3.2 Future

VRTS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.44% yearly.
The Revenue is expected to decrease by -0.82% on average over the next years.
EPS Next Y-2%
EPS Next 2Y1.31%
EPS Next 3Y3.44%
EPS Next 5YN/A
Revenue Next Year-5.61%
Revenue Next 2Y-1.58%
Revenue Next 3Y-0.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VRTS Yearly Revenue VS EstimatesVRTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
VRTS Yearly EPS VS EstimatesVRTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.59, which indicates a rather cheap valuation of VRTS.
Based on the Price/Earnings ratio, VRTS is valued cheaply inside the industry as 89.45% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of VRTS to the average of the S&P500 Index (27.24), we can say VRTS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.40, the valuation of VRTS can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VRTS indicates a rather cheap valuation: VRTS is cheaper than 91.56% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.82. VRTS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.59
Fwd PE 7.4
VRTS Price Earnings VS Forward Price EarningsVRTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VRTS is valued cheaply inside the industry as 81.86% of the companies are valued more expensively.
VRTS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 53.52
EV/EBITDA 13.83
VRTS Per share dataVRTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.61
EPS Next 2Y1.31%
EPS Next 3Y3.44%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.08%, VRTS is a good candidate for dividend investing.
VRTS's Dividend Yield is comparable with the industry average which is at 7.89.
Compared to an average S&P500 Dividend Yield of 2.32, VRTS pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.08%

5.2 History

The dividend of VRTS is nicely growing with an annual growth rate of 17.66%!
VRTS has been paying a dividend for at least 10 years, so it has a reliable track record.
VRTS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)17.66%
Div Incr Years7
Div Non Decr Years10
VRTS Yearly Dividends per shareVRTS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

VRTS pays out 50.06% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of VRTS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP50.06%
EPS Next 2Y1.31%
EPS Next 3Y3.44%
VRTS Yearly Income VS Free CF VS DividendVRTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M
VRTS Dividend Payout.VRTS Dividend Payout, showing the Payout Ratio.VRTS Dividend Payout.PayoutRetained Earnings

VIRTUS INVESTMENT PARTNERS

NYSE:VRTS (8/22/2025, 8:04:00 PM)

After market: 200.26 0 (0%)

200.26

+11.21 (+5.93%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-25 2025-07-25/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners83.91%
Inst Owner Change-0.51%
Ins Owners5.69%
Ins Owner Change3.05%
Market Cap1.35B
Analysts46.67
Price Target198.65 (-0.8%)
Short Float %1.98%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield 5.08%
Yearly Dividend8.27
Dividend Growth(5Y)17.66%
DP50.06%
Div Incr Years7
Div Non Decr Years10
Ex-Date10-31 2025-10-31 (2.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.4%
Min EPS beat(2)-1%
Max EPS beat(2)3.8%
EPS beat(4)1
Avg EPS beat(4)-0.12%
Min EPS beat(4)-3.1%
Max EPS beat(4)3.8%
EPS beat(8)2
Avg EPS beat(8)-1.59%
EPS beat(12)4
Avg EPS beat(12)-1.43%
EPS beat(16)6
Avg EPS beat(16)-0.52%
Revenue beat(2)0
Avg Revenue beat(2)-2.88%
Min Revenue beat(2)-3.81%
Max Revenue beat(2)-1.95%
Revenue beat(4)0
Avg Revenue beat(4)-3.08%
Min Revenue beat(4)-3.81%
Max Revenue beat(4)-1.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.65%
Revenue beat(12)3
Avg Revenue beat(12)0.58%
Revenue beat(16)7
Avg Revenue beat(16)3.89%
PT rev (1m)15.58%
PT rev (3m)15.58%
EPS NQ rev (1m)0.77%
EPS NQ rev (3m)0.25%
EPS NY rev (1m)0%
EPS NY rev (3m)2.08%
Revenue NQ rev (1m)1.25%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)1.79%
Valuation
Industry RankSector Rank
PE 7.59
Fwd PE 7.4
P/S 1.53
P/FCF 53.52
P/OCF 42.58
P/B 1.55
P/tB 10.54
EV/EBITDA 13.83
EPS(TTM)26.4
EY13.18%
EPS(NY)27.05
Fwd EY13.51%
FCF(TTM)3.74
FCFY1.87%
OCF(TTM)4.7
OCFY2.35%
SpS130.66
BVpS129.34
TBVpS19.01
PEG (NY)N/A
PEG (5Y)0.61
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 13.49%
ROCE 5.2%
ROIC 3.88%
ROICexc 4.03%
ROICexgc 5.22%
OM 20.14%
PM (TTM) 13.35%
GM N/A
FCFM 2.86%
ROA(3y)3.19%
ROA(5y)3.43%
ROE(3y)14.36%
ROE(5y)15.89%
ROIC(3y)3.76%
ROIC(5y)4.34%
ROICexc(3y)10.87%
ROICexc(5y)12.89%
ROICexgc(3y)110.04%
ROICexgc(5y)160.56%
ROCE(3y)5.04%
ROCE(5y)5.81%
ROICexcg growth 3Y-77.85%
ROICexcg growth 5Y3.06%
ROICexc growth 3Y-48.2%
ROICexc growth 5Y2.75%
OM growth 3Y-17.09%
OM growth 5Y-2.7%
PM growth 3Y-14.2%
PM growth 5Y-2.84%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF 87.76
Debt/EBITDA 9.12
Cap/Depr 9.92%
Cap/Sales 0.74%
Interest Coverage 250
Cash Conversion 13.06%
Profit Quality 21.45%
Current Ratio 2.05
Quick Ratio 2.05
Altman-Z 0.86
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)10.41%
Cap/Depr(5y)9.08%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.82%
EPS 3Y-9.8%
EPS 5Y12.37%
EPS Q2Q%-4.29%
EPS Next Y-2%
EPS Next 2Y1.31%
EPS Next 3Y3.44%
EPS Next 5YN/A
Revenue 1Y (TTM)0.99%
Revenue growth 3Y-2.52%
Revenue growth 5Y10%
Sales Q2Q%-5.91%
Revenue Next Year-5.61%
Revenue Next 2Y-1.58%
Revenue Next 3Y-0.82%
Revenue Next 5YN/A
EBIT growth 1Y20.18%
EBIT growth 3Y-19.18%
EBIT growth 5Y7.03%
EBIT Next Year-2.18%
EBIT Next 3Y-0.19%
EBIT Next 5YN/A
FCF growth 1Y-84.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.05%
OCF growth 3Y-86.19%
OCF growth 5YN/A